You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Melbourne breast cancer trial to test Optiscan imaging device
- 2. Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
- 3. Global research trends in tryptophan metabolism and cancer: a bibliometric and visualization analysis (2005–2024)
- 4. Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis
- 5. Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget's disease
- 6. Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
- 7. Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study
- 8. Study reveals mechanisms behind common mutation and prostate cancer
- 9. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 10. Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies
Last updated at 10:23 GMT
Hot News Makers
Health/Pharma Companies
-
32486.55
-
29993.39
-
28498.22
-
23831.18
-
10501.47
-
8494.82
-
7549.50
-
6799.91
-
5680.94
-
5070.31
Drugs, Treatments, Trials
-
13993.51
-
12678.64
-
11544.81
-
5814.93
-
5655.83
-
2464.92
-
2186.27
-
2092.00
-
1574.12
-
1457.52
Last updated at 10:10 GMT
